These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 39028070)
1. A rare case of Gynura-segetum-related hepatic sinus obstruction syndrome complicated with alcoholic liver disease. Gao Y; Zhang X; Zhou X; Wang J; Gong L; Chen G J Pak Med Assoc; 2024 Jul; 74(7):1355-1357. PubMed ID: 39028070 [TBL] [Abstract][Full Text] [Related]
2. Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis. Li S; Li Y; Zhou C; Li H; Chen C; Peng C; Wang T; Liu F; Xiao J; Shi L Cardiovasc Intervent Radiol; 2023 Jul; 46(7):931-942. PubMed ID: 37225971 [TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. Zhang L; Li Q; Makamure J; Zhao D; Liu Z; Zheng C; Liang B BMC Gastroenterol; 2021 Jan; 21(1):26. PubMed ID: 33423668 [TBL] [Abstract][Full Text] [Related]
4. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt. Xiao J; Tu J; Zhang H; Zhang F; Zhang W; Xu H; Yin Q; Yang J; Han H; Wang Y; Zhang B; Peng C; Zou X; Zhang M; Zhuge Y Hepatol Int; 2021 Jun; 15(3):720-729. PubMed ID: 33507485 [TBL] [Abstract][Full Text] [Related]
6. Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate. Ou P; Liu X; Tang Z; Hou Z; Liu L; Liu J; Zhou S; Fang Z; Sun K; Chen Y; Chen X; Li Y; Chen J Curr Pharm Des; 2019; 25(35):3762-3768. PubMed ID: 31589115 [TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome. Olliff SP Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433 [TBL] [Abstract][Full Text] [Related]
8. Hepatic sinusoidal obstruction syndrome caused by the ingestion of Cen P; Ding J; Jin J J Int Med Res; 2021 Apr; 49(4):300060520980649. PubMed ID: 33845617 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt. Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of chronic Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt. Michl P; Bilzer M; Waggershauser T; Gülberg V; Rau HG; Reiser M; Gerbes AL J Hepatol; 2000 Mar; 32(3):516-20. PubMed ID: 10735624 [TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome. Zhou CZ; Wang RF; Lv WF; Fu YQ; Cheng DL; Zhu YJ; Hou CL; Ye XJ World J Gastroenterol; 2020 Jun; 26(24):3472-3483. PubMed ID: 32655270 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study. Wang Y; Qiao D; Li Y; Xu F BMC Gastroenterol; 2018 Oct; 18(1):156. PubMed ID: 30367628 [TBL] [Abstract][Full Text] [Related]
14. [Study of PA-HSOS severity grading to predict the prognosis of patients with PA-HSOS treated by transjugular intrahepatic portosystemic shunt]. Chen YR; Zhang W; Zhang M; Zhang F; Xiao JQ; Yin Q; Zhuge YZ Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):46-53. PubMed ID: 33541023 [No Abstract] [Full Text] [Related]
15. [A case of successful management of refractory ascites by transjugular intrahepatic portosystemic shunting (TIPS) in Budd-Chiari syndrome associated with alcoholic liver fibrosis]. Takahashi S; Takahashi M; Takada K; Kawano Y; Hagiwara S; Akiyama T; Sato T; Doi T; Miyanishi K; Sato Y; Kato J; Niitsu Y; Homma H; Neda H Nihon Shokakibyo Gakkai Zasshi; 2002 Sep; 99(9):1085-91. PubMed ID: 12355897 [No Abstract] [Full Text] [Related]
16. [Budd-Chiari syndrome in a patient with paroxysmal nocturnal haemoglobinuria]. Balta Z; Nattermann J; Flacke S; Sauerbruch T Dtsch Med Wochenschr; 2005 Oct; 130(40):2257-60. PubMed ID: 16208599 [TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome. He FL; Wang L; Zhao HW; Fan ZH; Zhao MF; Dai S; Yue ZD; Liu FQ World J Gastroenterol; 2015 Feb; 21(8):2413-8. PubMed ID: 25741149 [TBL] [Abstract][Full Text] [Related]
18. Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Huang Q; Zhang Q; Xu H; Zu M; Xiao J; Shen B Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):445-452. PubMed ID: 36719828 [TBL] [Abstract][Full Text] [Related]
19. Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome. Artru F; Moschouri E; Denys A Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101858. PubMed ID: 34999250 [TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature. Campos-Varela I; Castells L; Dopazo C; Pérez-Lafuente M; Allende H; Len O; Llopart L; Vargas V; Charco R Liver Transpl; 2012 Feb; 18(2):201-5. PubMed ID: 21656652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]